GABAPENTIN; VIGABATRIN. OTHERS. MEDICINES (EXCEPT PRODUCTS OF HEADINGS 3002 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS PREPARED FOR THERAPEUTIC OR PROPHYLACTIC USES DOSED (INCLUDING THOSE ADMINISTERED|| SABRIL 500MG|| ENV X 60 COMP. 06/2026
GABAPENTIN; VIGABATRIN. OTHERS. MEDICINES (EXCEPT PRODUCTS OF HEADINGS 3002 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS PREPARED FOR THERAPEUTIC OR PROPHYLACTIC USES DOSED (INCLUDING THOSE ADMINISTERED|| SABRIL 500MG|| ENV X 60 COMP. 06/2026
DORAGABA3C- GABAPENTIN 300MG CAPS. (LIC.NO.TL/CT/20/000028) (FOR THE PURPOSE OF CLINICAL TRIAL)
DORAGABA3C- GABAPENTIN 300MG CAPS. (LIC.NO.TL/CT/20/000028) (FOR THE PURPOSE OF CLINICAL TRIAL)
23-November-2023
300490394000
GABAPENTIN; VIGABATRIN. OTHERS. MEDICINES (EXCEPT PRODUCTS OF HEADINGS 3002 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS PREPARED FOR THERAPEUTIC OR PROPHYLACTIC USES DOSED (INCLUDING THOSE ADMINISTERED|| SABRIL 500MG|| ENV X 60 COMP. 11/2025
GABAPENTIN; VIGABATRIN. OTHERS. MEDICINES (EXCEPT PRODUCTS OF HEADINGS 3002 3005 OR 3006) CONSISTING OF MIXED OR UNMIXED PRODUCTS PREPARED FOR THERAPEUTIC OR PROPHYLACTIC USES DOSED (INCLUDING THOSE ADMINISTERED|| SABRIL 500MG|| ENV X 60 COMP. 11/2025
11-May-2022
300490990000
DORAGABA3C- GABAPENTIN 300MG CAPS (LIC NO.TL/CT/20/000034 DT.18.02.2020) (FOR THE PURPOSE OF CLINICAL TRIAL)
DORAGABA3C- GABAPENTIN 300MG CAPS (LIC NO.TL/CT/20/000034 DT.18.02.2020) (FOR THE PURPOSE OF CLINICAL TRIAL)
10-January-2023
300490394000
GABAPENTIN; VIGABATRIN. OTHERS. MEDICINES (EXCEPT PRODUCTS OF THE PA|| SABRIL|| PACK X 60 COMP. 08/2025
GABAPENTIN; VIGABATRIN. OTHERS. MEDICINES (EXCEPT PRODUCTS OF THE PA|| SABRIL|| PACK X 60 COMP. 08/2025